Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment

Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment

Background: Chronic lymphocytic leukemia (CLL) is one of the most common hematological malignancies. In patients with CLL, serum immunoglobulin levels decrease over time due to both the disease itself and the chemo-immunotherapeutic agents used. It was aimed to reveal the relationship between hypoga...

Full description

Bibliographic Details
Main Authors:	Osman Yokus, Konul Jafarli, Fettah Sametoglu, Hasan Goze, Istemi Serin
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2022-01-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	Immunodeficiency; Chronic lymphocytic leukemia (CLL); Monoclonal antibody; Immunotherapy; Immunoglobulin G (IgG)
Online Access:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1347

Similar Items

OVERCOMING IMMUNODEFICIENCY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: CURRENT KNOWLEDGE AND PERSPECTIVES
by: Fabienne McClanahan, et al.
Published: (2014-07-01)

Spatial organization and early signaling of the B-cell receptor in CLL
by: Yamit Shorer Arbel, et al.
Published: (2022-08-01)

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab
by: Akie Hirata, et al.
Published: (2022-12-01)

Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis
by: Maria Denaro, et al.
Published: (2023-03-01)

" In vitro Glycation of Human IgG and Its Effect on Interaction with Anti-IgG "
by: Mohammad Taghi Goodarzi, et al.
Published: (2004-12-01)

Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review
by: Graham Walter, et al.
Published: (2020-05-01)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
by: Ewelina Grywalska, et al.
Published: (2020-11-01)

T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
by: Elisavet Vlachonikola, et al.
Published: (2021-06-01)

Dermatose por IgA e IgG linear: relato de caso com boa resposta terapêutica à dapsona e ao micofenolato mofetil Linear IgA/IgG bullous dermatosis: successful treatment with dapsone and mycophenolate mofetil
by: Leny Passos, et al.
Published: (2011-08-01)

A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report
by: Daisuke Ito, et al.
Published: (2022-12-01)

Specific IgG and its subclass antibodies after immunotherapy with gynandropsis gynandra
by: Latha G, et al.
Published: (2005-01-01)

Therapy of chronic lymphocytic leukemia (CLL) - from past to present
by: Anna Gumieniczek, et al.
Published: (2020-02-01)

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia
by: Matthew Kaufman, et al.
Published: (2022-07-01)

The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection
by: Spencer Boyle, et al.
Published: (2022-09-01)

Anion exchange chromatographic distribution of human monoclonal immunoglobulin G is determined by heavy chain subclass and level of sialic acid expression
by: Ilić Vesna, et al.
Published: (2012-01-01)

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
by: Naseba Naseraldeen, et al.
Published: (2021-02-01)

Conjugation of Synthetic Trisaccharide of Staphylococcus aureus Type 8 Capsular Polysaccharide Elicits Antibodies Recognizing Intact Bacterium
by: Ming Zhao, et al.
Published: (2020-04-01)

Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies
by: Cholpon Tilegenova, et al.
Published: (2020-01-01)

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions
by: Pin-Kuang Lai, et al.
Published: (2021-01-01)

IgG4 related pericardium and lung disease in pediatric patient complicated with fatal massive hemoptysis: a case report and review of literature
by: Moustafa Ali Saad, et al.
Published: (2023-02-01)

Case report: Clinical highlights and radiological classification of IgG4-related spinal pachymeningitis: A rare case series and updated review of the literature
by: Fan Yang, et al.
Published: (2023-01-01)

Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites
by: Ugochi Ebinama, et al.
Published: (2022-09-01)

Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections
by: Jeroen D. Langereis, et al.
Published: (2018-08-01)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
by: Stanislav Khil'chenko, et al.
Published: (2020-09-01)

B-Cell Chronic Lymphocytic Leukemia and Colon Adenocarcinoma in the Same Mesenteric Lymph Node
by: Ahmet Emre Eşkazan, et al.
Published: (2013-03-01)

IgG2 immunodeficiency: association to pediatric patients with bacterial meningoencephalitis
by: XIOMARA ESCOBAR-PÉREZ, et al.
Published: (2000-03-01)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
by: Myrthe E. Sonneveld, et al.
Published: (2018-01-01)

Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design
by: Martyn A. French, et al.
Published: (2017-07-01)

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
by: Christian Sordo-Bahamonde, et al.
Published: (2021-04-01)

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
by: Benjamin S. Haslund-Gourley, et al.
Published: (2023-03-01)

Preparasi Imunoglobulin G Kelinci sebagai Antigen Penginduksi Antibodi Spesifik Terhadap Virus Avian Influenza H5N1 Strain Legok
by: Ketut Karuni Nyanakumari Natih, et al.
Published: (2010-06-01)

The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis
by: Miroslav Vujasinovic, et al.
Published: (2023-12-01)

Increased Serum IgG4 Associates with Asthma and Tissue Eosinophilia in Chronic Rhinosinusitis Patients
by: Mahnaz Ramezanpour, et al.
Published: (2020-10-01)

Immunomodulating Enzymes from <i>Streptococcus pyogenes</i>—In Pathogenesis, as Biotechnological Tools, and as Biological Drugs
by: Lotta Happonen, et al.
Published: (2024-01-01)

The Future of Chronic Lymphocytic Leukemia Treatment- Balancing Efficacy, Safety and Cost
by: Valentin Goede, et al.
Published: (2013-10-01)

The Role of Monoclonal Antibodies in the Management of Leukemia
by: Mohamad Cherry, et al.
Published: (2010-10-01)

Lymphocytic Choriomeningitis Virus Infections and Seroprevalence, Southern Iraq
by: Hussein Alburkat, et al.
Published: (2020-12-01)

Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1–4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies
by: Itziar Ubillos, et al.
Published: (2018-06-01)

Role of immunological alterations in oral submucous fibrosis
by: Sarada Malempati, et al.
Published: (2019-01-01)